This week, we will discuss a double header: two single centre ddAVP trials in kidney biopsy from India.

This week, we will discuss the prognostic role of microvascular inflammation in kidney transplantation. Can the capillaries whisper their damage in lesions before antibodies speak? Maybe this study compels us to treat the injury we see, not just the disease we can name…

NephTrials: where NephJC joins forces with ISN ACT and ISN Academy, to bring the social media expertise from the NephJC community and the methods expertise from ISN-ACT.

In this edition of #Nephstats, we look at Number Needed to Treat (NNT), a controversial topic creates ripples and roars on social media amongst stat savvy physicians, epidemiologists and biostatisticians. This seems like such a simple and easy number to make sense of a trial’s importance - what could be controversial or wrong about it?

How do you understand the inverted world of non-inferiority? Manasi Bapat breaks it down for us here

She’s back: A stats explainer of statistical modelling, goodness of fit and the Bayes information criterion from Manasi Bapat.

When a study is negative the work is not done. Time to separate a negative trial from an underpowered one. Learn how to think about this with Manasi Bapat.

Propensity scores…what’s up with that?

Multiple testing and the Bonferroni - NSMC intern and NephJC stats explainer Manasi Bapat breaks it down for you in this post. 

Manasi deconstructs pragmatic trials for us. How are they different compared to efficacy & explanatory trials? 

Manasi Bapat takes you behind the scenes to explain the need for doing sensitivity analyses

We begin a series of occasional commentary on the methods underlying the research being discussed. This edition: the 2 x 2 factorial designs.